Jupiter Life Line Hospitals (JLHL) Q3 24/25 earnings summary

Executive summary

• Acquisition of a two-acre plot in Mira-Bhayandar for a sixth hospital, targeting a 2,500-bed network in Western India.

• Construction for the second Pune hospital to begin in March 2025, with regulatory approvals secured.

• Indore hospital expanded by 78 beds ahead of schedule, now at 309 beds.

• Dombivli hospital's first phase expected operational by Q1 FY27.

• Unaudited financial results for the quarter and nine months ended December 31, 2024, were approved by the Board on February 7, 2025.

Financial highlights

• Q3 FY25 consolidated income: ₹322 crores, up 17.7% year-over-year; EBITDA: ₹76.4 crores, up 21.5%; PAT: ₹52.5 crores, up 20.1%.

• 9M FY25 consolidated revenue: ₹934.8 crores, up 19.5% year-over-year; EBITDA: ₹218.3 crores, up 22%; PAT: ₹148.6 crores, up 13.2%.

• Gross profit margin for 9M FY25 was 81.9%; EBITDA margin at 23.4%; PAT margin at 15.9%.

• Standalone and consolidated net profit and EPS increased year-over-year for both Q3 and 9M FY25.

• PBT for 9M FY25 increased by 46.8% year-over-year to ₹195.6 crores.

Outlook and guidance

• Construction of new hospitals in Pune and Dombivli to begin in March 2025 and be operational by 2028 and Q1 FY27, respectively.

• Mira Road hospital targeted for 2029.

• New hospitals expected to be EBITDA negative in year 1, break-even in year 2, and positive in year 3.

• Expansion aligns with the medium-term goal of a 2,500-bed network in Western India.